On July 30, 2026, Thales (Euronext Paris: HO) and Exail Technologies (Euronext Paris: EXA) signed a tender offer agreement, the negotiation of which was announced on July 6, 2026.

This tender offer agreement sets forth the terms of the acquisition by Thales of all shares and ODIRNANE bonds issued by Exail Technologies, but which are not held by the Gorgé family, by way of a mandatory tender offer (the “Offer”). The Offer will be filed by Thales following closing of the acquisition of the Gorgé family’s stake, which represents 35.51% of the share capital of Exail Technologies . Terms and conditions of such acquisition, and of the Offer, including the €134.00 price per share, remain unchanged compared to the announcement made on July 6.

The Board of Directors of Exail Technologies, upon proposal of the ad hoc committee, has appointed Ledouble, represented by Olivier Cretté and Romain Delafont, as independent expert in connection with the Offer. It should be noted that this transaction has been unanimously and favourably welcomed by the Board of Directors of Exail Technologies which will be in charge of issuing a reasoned opinion (“avis motivé”) upon review of the fairness opinion to be issued by the independent expert.

As previously announced, closing of the acquisition of the Gorgé family’s stake is expected by Q3 2027, upon satisfaction of customary regulatory approvals (including antitrust). The mandatory tender offer for 100% of Exail Technologies’ shares and ODIRNANE bonds will be filed afterwards with the Autorité des marches financiers, and is expected to close at the beginning of 2028 at the latest.